Early stellate cell activation and veno-occlusive-disease (VOD)-like hepatotoxicity in dogs treated with AR-H047108, an imidazopyridine proton pump inhibitor.
about
Vonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidenceCharacterization of a novel potassium-competitive acid blocker of the gastric H,K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438).Pharmacokinetic Drug-Drug Interactions Between Vonoprazan and Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drugs: A Phase 2, Open-Label, Study in Healthy Japanese MenCharacteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438).
P2860
Early stellate cell activation and veno-occlusive-disease (VOD)-like hepatotoxicity in dogs treated with AR-H047108, an imidazopyridine proton pump inhibitor.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Early stellate cell activation ...... yridine proton pump inhibitor.
@en
Early stellate cell activation ...... yridine proton pump inhibitor.
@nl
type
label
Early stellate cell activation ...... yridine proton pump inhibitor.
@en
Early stellate cell activation ...... yridine proton pump inhibitor.
@nl
prefLabel
Early stellate cell activation ...... yridine proton pump inhibitor.
@en
Early stellate cell activation ...... yridine proton pump inhibitor.
@nl
P2093
P2860
P356
P1476
Early stellate cell activation ...... pyridine proton pump inhibitor
@en
P2093
Anna-Karin Lindström
Anna-Lena Berg
Enar Carlsson
Gerhard Böttcher
Heike Hellmold
Inger Skånberg-Wilhelmsson
Kjell Andersson
Russell Huby
P2860
P304
P356
10.1177/0192623308320802
P407
P50
P577
2008-07-22T00:00:00Z